TY - JOUR
T1 - Epigenetic regulation of neural stem cell differentiation towards spinal cord regeneration
AU - Kameda, Tomonori
AU - Imamura, Takuya
AU - Nakashima, Kinichi
N1 - Publisher Copyright:
© 2017, Springer-Verlag GmbH Germany.
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2018/1/1
Y1 - 2018/1/1
N2 - Severe spinal cord injury (SCI) leads to almost complete neural cell loss at the injured site, causing the irreversible disruption of neuronal circuits. The transplantation of neural stem or precursor cells (NS/PCs) has been regarded as potentially effective for SCI treatment because NS/PCs can compensate for the injured sites by differentiating into neurons and glial cells (astrocytes and oligodendrocytes). An understanding of the molecular mechanisms that regulate the proliferation, fate specification and maturation of NS/PCs and their progeny would facilitate the establishment of better therapeutic strategies for regeneration after SCI. In recent years, several studies of SCI animal models have demonstrated that the modulation of specific epigenetic marks by histone modifiers and non-coding RNAs directs the setting of favorable cellular environments that promote the neuronal differentiation of NS/PCs and/or the elongation of the axons of the surviving neurons at the injured sites. In this review, we provide an overview of recent progress in the epigenetic regulation/manipulation of neural cells for the treatment of SCI.
AB - Severe spinal cord injury (SCI) leads to almost complete neural cell loss at the injured site, causing the irreversible disruption of neuronal circuits. The transplantation of neural stem or precursor cells (NS/PCs) has been regarded as potentially effective for SCI treatment because NS/PCs can compensate for the injured sites by differentiating into neurons and glial cells (astrocytes and oligodendrocytes). An understanding of the molecular mechanisms that regulate the proliferation, fate specification and maturation of NS/PCs and their progeny would facilitate the establishment of better therapeutic strategies for regeneration after SCI. In recent years, several studies of SCI animal models have demonstrated that the modulation of specific epigenetic marks by histone modifiers and non-coding RNAs directs the setting of favorable cellular environments that promote the neuronal differentiation of NS/PCs and/or the elongation of the axons of the surviving neurons at the injured sites. In this review, we provide an overview of recent progress in the epigenetic regulation/manipulation of neural cells for the treatment of SCI.
UR - http://www.scopus.com/inward/record.url?scp=85022184568&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85022184568&partnerID=8YFLogxK
U2 - 10.1007/s00441-017-2656-2
DO - 10.1007/s00441-017-2656-2
M3 - Review article
C2 - 28695279
AN - SCOPUS:85022184568
SN - 0302-766X
VL - 371
SP - 189
EP - 199
JO - Cell and Tissue Research
JF - Cell and Tissue Research
IS - 1
ER -